XML 47 R37.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Recent Transactions, Telavant Disposition (Details) - USD ($) $ in Thousands |  | 2 Months Ended | 3 Months Ended | 8 Months Ended | 9 Months Ended
--- | --- | --- | --- | --- | ---
Dec. 14, 2023 | Dec. 14, 2023 | Dec. 31, 2022 | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 14, 2023 | Dec. 31, 2023 | Dec. 31, 2022
Consideration [Abstract] |  |  |  |  |  |  |  |
Gain on sale of Telavant net assets |  |  |  | $ 5,348,410 | $ 0 |  | $ 5,348,410 | $ 0
Telavant Holdings, Inc. [Member] |  |  |  |  |  |  |  |
Consideration [Abstract] |  |  |  |  |  |  |  |
Pretax loss |  | $ (27,300) | $ (89,400) |  |  | $ (71,100) |  |
Telavant Holdings, Inc. [Member] | RSL [Member] |  |  |  |  |  |  |  |
Telavant Disposition [Abstract] |  |  |  |  |  |  |  |
Ownership percentage | 75.00% | 75.00% |  |  |  | 75.00% |  |
Consideration [Abstract] |  |  |  |  |  |  |  |
Gain on sale of Telavant net assets |  |  |  | $ 5,300,000 |  |  | $ 5,300,000 |
Telavant Holdings, Inc. [Member] | Pfizer [Member] |  |  |  |  |  |  |  |
Telavant Disposition [Abstract] |  |  |  |  |  |  |  |
Ownership percentage | 25.00% | 25.00% |  |  |  | 25.00% |  |
Roche Transaction [Member] |  |  |  |  |  |  |  |
Consideration [Abstract] |  |  |  |  |  |  |  |
Upfront cash payment | $ 7,100,000 |  |  |  |  |  |  |
Consideration to be received from milestone | 150,000 |  |  |  |  |  |  |
Roche Transaction [Member] | RSL [Member] |  |  |  |  |  |  |  |
Consideration [Abstract] |  |  |  |  |  |  |  |
Upfront cash payment | 5,234,373 |  |  |  |  |  |  |
Consideration to be received from milestone | 110,000 |  |  |  |  |  |  |
Carrying amount of noncontrolling interest derecognized | 87,500 | $ 87,500 |  |  |  | $ 87,500 |  |
Total consideration | 5,321,873 | 5,321,873 |  |  |  | 5,321,873 |  |
Assets sold | 3,253 | 3,253 |  |  |  | 3,253 |  |
Liabilities transferred | 29,790 | 29,790 |  |  |  | 29,790 |  |
Net liabilities sold | (26,537) | $ (26,537) |  |  |  | $ (26,537) |  |
Gain on sale of Telavant net assets | $ 5,348,410 |  |  |  |  |  |  |

X
- Definition Amount of consideration received for sale of assets. + References No definition available. + Details
Name: | roiv_ConsiderationReceivedForSaleOfAssets
Namespace Prefix: | roiv_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- References No definition available. + Details
Name: | roiv_DisposalGroupAbstract
Namespace Prefix: | roiv_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount classified as assets attributable to disposal group held for sale. + References No definition available. + Details
Name: | roiv_DisposalGroupAssets
Namespace Prefix: | roiv_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- References No definition available. + Details
Name: | roiv_DisposalGroupConsiderationAbstract
Namespace Prefix: | roiv_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount classified as liabilities attributable to disposal group held for sale. + References No definition available. + Details
Name: | roiv_DisposalGroupLiabilities
Namespace Prefix: | roiv_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount classified as net assets (liabilities) attributable to disposal group held for sale. + References No definition available. + Details
Name: | roiv_DisposalGroupNetAssetsLiabilities
Namespace Prefix: | roiv_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The carrying amount of noncontrolling interest derecognized attributable to disposal group held for sale. + References No definition available. + Details
Name: | roiv_DisposalGroupNoncontrollingInterestDerecognizedValue
Namespace Prefix: | roiv_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The future milestone to be received from sale of assets. + References No definition available. + Details
Name: | roiv_FutureMilestoneToBeReceivedFromSaleOfAssets
Namespace Prefix: | roiv_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of gain (loss) on sale of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee. + References No definition available. + Details
Name: | roiv_GainLossOnSaleOfAssets
Namespace Prefix: | roiv_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of before tax of income (loss) from a disposal group. + References No definition available. + Details
Name: | roiv_IncomeLossFromDisposalGroupBeforeIncomeTax
Namespace Prefix: | roiv_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The percentage of ownership interest. + References No definition available. + Details
Name: | roiv_OwnershipPercentage
Namespace Prefix: | roiv_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of upfront cash payment received for sale of assets. + References No definition available. + Details
Name: | roiv_UpfrontCashPaymentReceivedForSaleOfAssets
Namespace Prefix: | roiv_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=roiv_TelavantHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=roiv_RSLMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=roiv_PfizerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=roiv_RocheTransactionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |